Challenges in Glioblastoma Radiomics and the Path to Clinical Implementation

SIMPLE SUMMARY: Glioblastoma (GBM) is a cancer with poor prognosis, its 5-year survival expectation is approximately 5%. Advances in oncologic treatment techniques have not led to significant improvements in survival outcomes for GBM patients. Part of the reason for the treatment failures in GBM pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Philip, Holloway, Lois, Metcalfe, Peter, Koh, Eng-Siew, Brighi, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406186/
https://www.ncbi.nlm.nih.gov/pubmed/36010891
http://dx.doi.org/10.3390/cancers14163897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406186/
https://www.ncbi.nlm.nih.gov/pubmed/36010891
http://dx.doi.org/10.3390/cancers14163897

Ejemplares similares